Bianca M. Liederer
Publications by Year
Research Areas
Sirtuins and Resveratrol in Medicine, PI3K/AKT/mTOR signaling in cancer, PARP inhibition in cancer therapy, Biochemical and Molecular Research, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Enzymes involved in the bioconversion of ester-based prodrugs(2006)364 cited
- → Targeting Activated Akt with GDC-0068, a Novel Selective Akt Inhibitor That Is Efficacious in Multiple Tumor Models(2013)293 cited
- → Discovery and Preclinical Pharmacology of a Selective ATP-Competitive Akt Inhibitor (GDC-0068) for the Treatment of Human Tumors(2012)184 cited
- → RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases(2019)141 cited
- → A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment(2021)130 cited
- → Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design(2016)102 cited
- → Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases(2019)97 cited
- → Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State(2018)92 cited
- → GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models(2020)88 cited
- → Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase(2014)83 cited